Smith & Nephew (NYSE:SNN) Research Coverage Started at Sanford C. Bernstein

Sanford C. Bernstein started coverage on shares of Smith & Nephew (NYSE:SNN) in a research note issued to investors on Tuesday morning, The Fly reports. The firm issued an outperform rating on the medical equipment provider’s stock.

SNN has been the topic of a number of other research reports. Berenberg Bank upgraded shares of Smith & Nephew from a hold rating to a buy rating in a research report on Tuesday, July 23rd. ValuEngine lowered shares of Smith & Nephew from a hold rating to a sell rating in a research report on Wednesday, October 2nd. Finally, Zacks Investment Research upgraded shares of Smith & Nephew from a sell rating to a hold rating in a research report on Saturday, November 2nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $27.50.

Shares of NYSE:SNN traded up $0.32 on Tuesday, reaching $43.21. 294,621 shares of the company’s stock were exchanged, compared to its average volume of 970,345. The company has a fifty day moving average of $45.21 and a 200-day moving average of $44.56. Smith & Nephew has a twelve month low of $35.39 and a twelve month high of $48.93. The company has a market capitalization of $18.84 billion, a price-to-earnings ratio of 21.39, a PEG ratio of 3.85 and a beta of 0.23. The company has a current ratio of 2.00, a quick ratio of 0.96 and a debt-to-equity ratio of 0.40.

The company also recently declared a — dividend, which was paid on Wednesday, October 30th. Investors of record on Friday, October 4th were given a dividend of $0.288 per share. The ex-dividend date was Thursday, October 3rd. This represents a dividend yield of 1.5%. Smith & Nephew’s dividend payout ratio is 27.72%.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Boston Common Asset Management LLC boosted its position in shares of Smith & Nephew by 7.1% during the 2nd quarter. Boston Common Asset Management LLC now owns 20,425 shares of the medical equipment provider’s stock worth $889,000 after acquiring an additional 1,361 shares in the last quarter. Foresters Investment Management Company Inc. boosted its position in shares of Smith & Nephew by 1.5% during the 2nd quarter. Foresters Investment Management Company Inc. now owns 857,050 shares of the medical equipment provider’s stock worth $37,316,000 after acquiring an additional 12,550 shares in the last quarter. SG Americas Securities LLC boosted its position in shares of Smith & Nephew by 354.0% during the 2nd quarter. SG Americas Securities LLC now owns 42,131 shares of the medical equipment provider’s stock worth $1,834,000 after acquiring an additional 32,852 shares in the last quarter. Bank of Montreal Can boosted its position in shares of Smith & Nephew by 1.7% during the 2nd quarter. Bank of Montreal Can now owns 19,680 shares of the medical equipment provider’s stock worth $856,000 after acquiring an additional 328 shares in the last quarter. Finally, Advisor Partners LLC boosted its position in shares of Smith & Nephew by 20.3% during the 3rd quarter. Advisor Partners LLC now owns 6,494 shares of the medical equipment provider’s stock worth $313,000 after acquiring an additional 1,097 shares in the last quarter. Institutional investors and hedge funds own 9.11% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

See Also: What is channel trading?

The Fly

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.